CGP-82996

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCGP-82996
Drug Alias Namecyclin-dependent kinase-4 inhibitor (Novartis)CDK-4 inhibitor (Novartis)CINK-4CGP-82996
ClassificationSmall molecules
Mechanisms of ActionCell cycle inhibitorsCyclin-dependent kinase 4 inhibitorsAnticancer protein kinase inhibitors
TargetsCyclin-dependent kinase 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A